BioNano Genomics (BNGO) Q3 2022 Earnings Report
0 Followers
MX:BNGO Q3 2022 EPS Results
- Actual EPS
- -MXN 1,235.96
- Consensus EPS
- -MXN 1,273.41
- Beat/Miss
- Beat by +MXN 37.45
- One Year Ago EPS
- -MXN 786.52
MX:BNGO Q3 2022 Revenue Results
- Actual Revenue
- MXN 135.22M
- Expected Revenue
- MXN 127.23M
- Beat/Miss
- Beat by +MXN 8.00M
- YoY Revenue Growth
- +55.12%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/03/2022
- Time
- After Close
- Conference Call
- Thursday, November 3, 2022
MX:BNGO Upcoming Earnings
BioNano Genomics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q3 2022 Earnings Call Audio
MX:BNGO Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNGO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -8.43- | -38.2 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -12.55-12.36 | -37.45 | 67.00% (+25.09) | |
| May 13, 2026 | 2026 (Q1) | -16.48-14.23 | -21.54 | 33.91% (+7.30) | |
| Mar 23, 2026 | 2025 (Q4) | -46.35-29.03 | -227.25 | 87.23% (+198.22) | |
| Nov 13, 2025 | 2025 (Q3) | -38.86-38.20 | -584.27 | 93.46% (+546.07) | |
| Aug 14, 2025 | 2025 (Q2) | -49.76-37.45 | -269.66 | 86.11% (+232.21) | |
| May 14, 2025 | 2025 (Q1) | ―- | -674.16 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -56.61-21.54 | -674.16 | 96.81% (+652.62) | |
| Nov 13, 2024 | 2024 (Q3) | -221.93-584.27 | -3617.98 | 83.85% (+3033.71) | |
| Aug 07, 2024 | 2024 (Q2) | -466.63-269.66 | -1393.26 | 80.65% (+1123.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
